Bullish
OrbiMed funds add Prelude Therapeutics (PRLD) shares at $4.44 in offering
Funds associated with OrbiMed have significantly increased their stake in Prelude Therapeutics (PRLD) by purchasing 2,815,315 shares at $4.44 per shar...